NI­AID di­rec­tor An­tho­ny Fau­ci gained hero sta­tus amid the pan­dem­ic, earn­ing Amer­i­cans’ trust and even Time mag­a­zine’s Guardian of the Year ti­tle. But he and oth­er fed­er­al health of­fi­cials have al­so faced in­tense threats, ac­cord­ing to charges brought by the US De­part­ment of Jus­tice.

A West Vir­ginia man is fac­ing up to 10 years in prison af­ter threat­en­ing Fau­ci, for­mer NIH di­rec­tor Fran­cis Collins, and HHS as­sis­tant sec­re­tary for health Rachel Levine via email, the DOJ said on Mon­day. Thomas Patrick Con­nal­ly, Jr., plead­ed guilty on Mon­day to us­ing an anony­mous email ad­dress to threat­en the of­fi­cials for per­form­ing their of­fi­cial du­ties, in­clud­ing dis­cussing Covid-19 test­ing and pre­ven­tion.

In one email, Con­nal­ly wrote that Fau­ci and his fam­i­ly would be “dragged in­to the street, beat­en to death, and set on fire.”

The 56-year-old al­so sent a se­ries of emails threat­en­ing Collins and his fam­i­ly with phys­i­cal as­sault and death if the for­mer NIH of­fi­cial didn’t stop speak­ing about the need for manda­to­ry Covid vac­cines.

“As stat­ed in his plea agree­ment, Con­nal­ly ad­mit­ted that he sent the threats to Drs. Fau­ci and Collins with the in­tent to in­tim­i­date or in­ter­fere with the per­for­mance of their of­fi­cial du­ties and with the in­tent to re­tal­i­ate against Dr. Fau­ci and Dr. Collins for per­form­ing their of­fi­cial du­ties, in­clud­ing dis­cussing Covid-19 and its test­ing and pre­ven­tion,” the DOJ said in a news re­lease.

Con­nal­ly is al­so charged with send­ing threats to a Mass­a­chu­setts pub­lic health of­fi­cial and a re­li­gious leader.

US Dis­trict Judge Paula Xi­nis has sched­uled a sen­tenc­ing for Aug. 4.

Two weeks ago, Biohaven hit an all-time high in weekly Nurtec prescriptions. CEO Vlad Coric attributes at least some of that success to a new interactive Twitter campaign that encourages patients to free their feed of potential migraine triggers.

Earlier this month, Biohaven in partnership with Twitter launched the #RelieveYourFeed campaign that allows users to customize their app settings based on their migraine triggers.

Over the past few months, oncologists have been talking a lot about the ASCO conference. Not surprising considering its import and the study data presented, but what may be less expected is the second most talked about topic of health equity.

That’s according to data from The Harris Poll and the new expert network the researcher is building out. While the company has been doing deep data dives into specific health issues or conditions for pharma clients, it’s now monitoring influencer networks of therapy area specialists to find out what experts are really thinking about.

Earlier this year, Novartis touted its radioligand as a major piece to counter competition in the cancer space. However, the physical production of its products has had anything but a smooth ride.

In May, Novartis had to suspend production of Lutathera and Pluvicto, its two primary radiotherapies. According to the company, this was done out of an abundance of caution as a result of potential quality issues identified in its manufacturing. The production suspension impacts the commercial and clinical trial supply of the products.

The rise of pharma environmental, social and governance (ESG) efforts in the past two years has been meteoric as investors turn their attention to sustainable funding. However, investors aren’t the only ones watching. Patients are beginning to tune into pharmas’ ESG promises too.

Patient advocacy groups familiar with ESG regard it as an important issue and want to be included in helping pharma companies set ESG policies and targets, according to a new report from PatientView. That’s quite different from what the investment community wants across a variety of Gartner’s defined financial, competitive, strategic and perception goals.